These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

474 related articles for article (PubMed ID: 31039731)

  • 21. Recognizing the role of CGRP and CGRP receptors in migraine and its treatment.
    Edvinsson L; Warfvinge K
    Cephalalgia; 2019 Mar; 39(3):366-373. PubMed ID: 29020807
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Calcitonin gene-related peptide (CGRP): a new target for migraine.
    Russo AF
    Annu Rev Pharmacol Toxicol; 2015; 55():533-52. PubMed ID: 25340934
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CGRP receptor antagonists for migraine. Are they also AMY
    Garelja ML; Walker CS; Hay DL
    Br J Pharmacol; 2022 Feb; 179(3):454-459. PubMed ID: 34076887
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Novel migraine therapy with calcitonin gene-regulated peptide receptor antagonists.
    Edvinsson L
    Expert Opin Ther Targets; 2007 Sep; 11(9):1179-88. PubMed ID: 17845144
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Erenumab in the treatment of migraine.
    Jain S; Yuan H; Spare N; Silberstein SD
    Pain Manag; 2018 Nov; 8(6):415-426. PubMed ID: 30235976
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Foreword: The CGRP Pathway and Migraine Prevention: Reducing the Burden of Disease.
    Holland PR
    Headache; 2018 May; 58 Suppl 1():1-3. PubMed ID: 29697155
    [No Abstract]   [Full Text] [Related]  

  • 27. Eptinezumab: First Approval.
    Dhillon S
    Drugs; 2020 May; 80(7):733-739. PubMed ID: 32266704
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A Review of the Potential Receptors of Migraine with a Special Emphasis on CGRP to Develop an Ideal Antimigraine Drug.
    Naduchamy KP; Parthasarathy V
    Curr Mol Pharmacol; 2021; 14(1):11-26. PubMed ID: 32838728
    [TBL] [Abstract][Full Text] [Related]  

  • 29. C-fibers may modulate adjacent Aδ-fibers through axon-axon CGRP signaling at nodes of Ranvier in the trigeminal system.
    Edvinsson JCA; Warfvinge K; Krause DN; Blixt FW; Sheykhzade M; Edvinsson L; Haanes KA
    J Headache Pain; 2019 Nov; 20(1):105. PubMed ID: 31718551
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Erenumab (AMG 334), a monoclonal antagonist antibody against the canonical CGRP receptor, does not impair vasodilatory or contractile responses to other vasoactive agents in human isolated cranial arteries.
    Ohlsson L; Haanes KA; Kronvall E; Xu C; Snellman J; Edvinsson L
    Cephalalgia; 2019 Dec; 39(14):1745-1752. PubMed ID: 31366221
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunohistochemical localization of the calcitonin gene-related peptide binding site in the primate trigeminovascular system using functional antagonist antibodies.
    Miller S; Liu H; Warfvinge K; Shi L; Dovlatyan M; Xu C; Edvinsson L
    Neuroscience; 2016 Jul; 328():165-83. PubMed ID: 27155150
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A new era for migraine: The role of calcitonin gene-related peptide in the trigeminovascular system.
    Chen ST; Wu JW
    Prog Brain Res; 2020; 255():123-142. PubMed ID: 33008504
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CGRP/CGRP Receptor Antibodies: Potential Adverse Effects Due to Blockade of Neovascularization?
    Majima M; Ito Y; Hosono K; Amano H
    Trends Pharmacol Sci; 2019 Jan; 40(1):11-21. PubMed ID: 30502971
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CGRP as the target of new migraine therapies - successful translation from bench to clinic.
    Edvinsson L; Haanes KA; Warfvinge K; Krause DN
    Nat Rev Neurol; 2018 Jun; 14(6):338-350. PubMed ID: 29691490
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CGRP receptor activity in mice with global expression of human receptor activity modifying protein 1.
    Bohn KJ; Li B; Huang X; Mason BN; Wattiez AS; Kuburas A; Walker CS; Yang P; Yu J; Heinz BA; Johnson KW; Russo AF
    Br J Pharmacol; 2017 Jun; 174(12):1826-1840. PubMed ID: 28317098
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cerebellar distribution of calcitonin gene-related peptide (CGRP) and its receptor components calcitonin receptor-like receptor (CLR) and receptor activity modifying protein 1 (RAMP1) in rat.
    Edvinsson L; Eftekhari S; Salvatore CA; Warfvinge K
    Mol Cell Neurosci; 2011 Jan; 46(1):333-9. PubMed ID: 21040789
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A Review of Monoclonal Antibody Therapies and Other Preventative Treatments in Migraine.
    Reuter U
    Headache; 2018 May; 58 Suppl 1():48-59. PubMed ID: 29697156
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Targeting CGRP via receptor antagonism and antibody neutralisation in two distinct rodent models of migraine-like pain.
    Christensen SL; Petersen S; Kristensen DM; Olesen J; Munro G
    Cephalalgia; 2019 Dec; 39(14):1827-1837. PubMed ID: 31288556
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Potential for treatment benefit of small molecule CGRP receptor antagonist plus monoclonal antibody in migraine therapy.
    Mullin K; Kudrow D; Croop R; Lovegren M; Conway CM; Coric V; Lipton RB
    Neurology; 2020 May; 94(20):e2121-e2125. PubMed ID: 31932515
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Calcitonin gene-related peptide: an update on the biology.
    Recober A; Russo AF
    Curr Opin Neurol; 2009 Jun; 22(3):241-6. PubMed ID: 19434786
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.